HUMAN CHORIONIC GONADOTROPIN 1 — Class II drug recall D-0237-2021
Terminated recall by Complete Pharmacy and Medical Solutions, LLC., reported 2021-01-27, distributed nationwide. CGMP deviations: Lack of potency testing.
| Recall number | D-0237-2021 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Complete Pharmacy and Medical Solutions, LLC., Miami Lakes, FL, United States |
| Recall initiated | 2020-11-20 |
| Classified | 2021-01-19 |
| Reported by FDA | 2021-01-27 |
| Terminated | 2022-09-28 |
| Distributed | Nationwide (US) |
| Quantity | 2,400 vials |
| Reason classes | potency, cgmp |
| Lot numbers | 40548 |
| Expiration dates | 2021-01-30 |
Product
HUMAN CHORIONIC GONADOTROPIN 1,250 IU per vial Aso contains Mannitol 9%, Sodium Phosphate 2% in water for injection. Lyophilized, Unpreserved. Complete Pharmacy & Medical Solutions 5829 NW 158th St, Miami Lakes, FL 33014 Tel: 305-397-2035
Reason for recall
CGMP deviations: Lack of potency testing.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0237-2021. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.